81 related articles for article (PubMed ID: 1708604)
1. [Histology, immunocytochemistry and DNA cytophotometry of adrenocortical tumors--a clinicomorphological study of 72 tumors].
Schröder S; Padberg BC; Achilles E; Lauritzen I; Dralle H; Klöppel G
Verh Dtsch Ges Pathol; 1990; 74():284-8. PubMed ID: 1708604
[TBL] [Abstract][Full Text] [Related]
2. Discerning malignancy in human adrenocortical neoplasms: utility of DNA flow cytometry and immunohistochemistry.
Suzuki T; Sasano H; Nisikawa T; Rhame J; Wilkinson DS; Nagura H
Mod Pathol; 1992 May; 5(3):224-31. PubMed ID: 1353877
[TBL] [Abstract][Full Text] [Related]
3. DNA cytophotometry in adrenocortical tumours: a clinicomorphological study of 66 cases.
Padberg BC; Lauritzen I; Achilles E; Holl K; Bressel M; Klöppel G; Dralle H; Schröder S
Virchows Arch A Pathol Anat Histopathol; 1991; 419(3):167-70. PubMed ID: 1926757
[TBL] [Abstract][Full Text] [Related]
4. Proliferative activity and genetic changes in adrenal cortical tumors examined by flow cytometry, fluorescence in situ hybridization and immunohistochemistry.
Takehara K; Sakai H; Shono T; Irie J; Kanetake H
Int J Urol; 2005 Feb; 12(2):121-7. PubMed ID: 15733104
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemistry in adrenocortical tumours: a clinicomorphological study of 72 neoplasms.
Schröder S; Padberg BC; Achilles E; Holl K; Dralle H; Klöppel G
Virchows Arch A Pathol Anat Histopathol; 1992; 420(1):65-70. PubMed ID: 1539453
[TBL] [Abstract][Full Text] [Related]
6. Nuclear DNA content and morphological characteristics in the prognosis of adrenocortical carcinoma.
Haak HR; Cornelisse CJ; Hermans J; Cobben L; Fleuren GJ
Br J Cancer; 1993 Jul; 68(1):151-5. PubMed ID: 8318407
[TBL] [Abstract][Full Text] [Related]
7. Image cytometric DNA analysis of adrenocortical neoplasms as a prognostic parameter: a clinico-pathologic study of 13 patients.
Lü X; Stallmach T; Gebbers JO
Anal Cell Pathol; 1996 Oct; 12(1):1-11. PubMed ID: 8933905
[TBL] [Abstract][Full Text] [Related]
8. [DNA cytophotometry of oxyphilic thyroid tumors].
Pilch H; Back W; Winter J
Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma.
Wick MR; Cherwitz DL; McGlennen RC; Dehner LP
Am J Pathol; 1986 Feb; 122(2):343-52. PubMed ID: 2418689
[TBL] [Abstract][Full Text] [Related]
10. Adrenal cortical adenoma and adrenal metastasis of renal cell carcinoma: immunohistochemical and DNA ploidy analysis.
Kumar D; Kumar S
Mod Pathol; 1993 Jan; 6(1):36-41. PubMed ID: 7678935
[TBL] [Abstract][Full Text] [Related]
11. [Flow-cytometric study of the DNA content in adrenal cortex tumors].
Tóth M; Molnár G; Schaff Z; Rácz K; Kiss R; Fütö L; Varga I; Gláz E; Lapis K
Orv Hetil; 1993 Jun; 134(26):1411-5. PubMed ID: 8332362
[TBL] [Abstract][Full Text] [Related]
12. [Histology, immunocytochemistry and DNA cytophotometry of adrenal glandpheochromocytoma (PCC)--a morphologic clinal study of 64 tumors].
Padberg BC; Achilles E; Garbe E; Dralle H; Klöppel G; Schröder S
Verh Dtsch Ges Pathol; 1990; 74():289-94. PubMed ID: 1708605
[TBL] [Abstract][Full Text] [Related]
13. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas.
Song SY; Park S; Kim SR; Suh YL
Pathol Int; 2004 Aug; 54(8):603-10. PubMed ID: 15260851
[TBL] [Abstract][Full Text] [Related]
14. DNA topoisomerase II alpha and Ki-67 in human adrenocortical neoplasms: a possible marker of differentiation between adenomas and carcinomas.
Iino K; Sasano H; Yabuki N; Oki Y; Kikuchi A; Yoshimi T; Nagura H
Mod Pathol; 1997 Sep; 10(9):901-7. PubMed ID: 9310953
[TBL] [Abstract][Full Text] [Related]
15. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
[TBL] [Abstract][Full Text] [Related]
16. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions.
Blanes A; Diaz-Cano SJ
Hum Pathol; 2006 Oct; 37(10):1295-303. PubMed ID: 16949934
[TBL] [Abstract][Full Text] [Related]
17. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms.
Nakazumi H; Sasano H; Iino K; Ohashi Y; Orikasa S
Mod Pathol; 1998 Dec; 11(12):1165-70. PubMed ID: 9872646
[TBL] [Abstract][Full Text] [Related]
18. Expression of p53 in adrenocortical tumours: clinicopathological correlations.
McNicol AM; Nolan CE; Struthers AJ; Farquharson MA; Hermans J; Haak HR
J Pathol; 1997 Feb; 181(2):146-52. PubMed ID: 9120717
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of adrenal cortical tumor DNA. Relationship between cellular DNA and histopathologic classification.
Bowlby LS; DeBault LE; Abraham SR
Cancer; 1986 Oct; 58(7):1499-505. PubMed ID: 3742468
[TBL] [Abstract][Full Text] [Related]
20. Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy.
Kjellman M; Kallioniemi OP; Karhu R; Höög A; Farnebo LO; Auer G; Larsson C; Bäckdahl M
Cancer Res; 1996 Sep; 56(18):4219-23. PubMed ID: 8797595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
